Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain

PHASE3CompletedINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Ankle Sprain
Interventions
DRUG

Diclofenac epolamine

Diclofenac epolamine in a topical patch formulation; applied to the area of sprained ankle; to treat pain associated with a mild ankle sprain

OTHER

Placebo

Topical patch not containing diclofenac epolamine applied to the area of sprained ankle; to treat pain associated with a mild ankle sprain

Trial Locations (31)

11201

Site 18, Brooklyn

16801

Site 27, State College

19355

Site 37, Downingtown

23606

Site 06, Newport News

24541

Site 31, Danville

32117

Site 11, Daytona Beach

Site 10, Omaha

32720

Site 09, DeLand

33144

Site 14, Miami

33155

Site 07, Miami

Site 13, Miami

33409

Site 02, West Palm Beach

35209

Site 21, Birmingham

40509

Site 26, Lexington

43214

Site 30, Columbus

45246

Site 19, Cincinnati

49684

Site 41, Traverse City

70056

Site 12, Gretna

73112

Site 35, Oklahoma City

77089

Site 34, Houston

77566

Site 36, Lake Jackson

78218

Site 22, San Antonio

78756

Site 15, Austin

84065

Site 03, Riverton

84105

Site 16, Clinton

85395

Site 24, Goodyear

Site 23, Kalamazoo

92008

Site 08, Carlsbad

93003

Site 05, Ventura

04, El Paso

08009

Site 29, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT02324270 - Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain | Biotech Hunter | Biotech Hunter